Metabolic engineering of microorganisms for the synthesis of plant natural products

Journal of Biotechnology

Volumn 163, Issue 2, 2013, Pages 166-178

  Marienhagen, Jan ^a   Bott, Michael ^a  

^a FORSCHUNGSZENTRUM JÜLICH   (Germany)

Author keywords

Alkaloids; Combinatorial biosynthesis; Coumarins; Flavonoids; Isoprenoids; Lignans; Metabolic engineering; Phenylpropanoids; Plant natural products; Secondary metabolism; Stilbenes; Synthetic biology; Terpenoids; Value added products

Indexed keywords

ALKALOIDS; COMBINATORIAL BIOSYNTHESIS; COUMARINS; ISOPRENOIDS; LIGNANS; NATURAL PRODUCTS; PHENYLPROPANOIDS; SECONDARY METABOLISM; STILBENES; SYNTHETIC BIOLOGY; TERPENOIDS; VALUE ADDED PRODUCTS;

BIOCHEMISTRY; BIOSYNTHESIS; DNA SEQUENCES; FLAVONOIDS; GENETIC ENGINEERING; LIPIDS; METABOLIC ENGINEERING; METABOLITES; MICROORGANISMS; NITROGEN COMPOUNDS;

PLANTS (BOTANY);

ALKALOID DERIVATIVE; CAROTENOID; FLAVONOID; GLUCOSINOLATE; ISOPRENE; ISOPRENOID; LIGNAN DERIVATIVE; NATURAL PRODUCT; PHENYLPROPANOID DERIVATIVE; PLANT NATURAL PRODUCT; POLYACETYLENE DERIVATIVE; POLYKETIDE; STEROL DERIVATIVE; STILBENE DERIVATIVE; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; ARTICLE; ESCHERICHIA COLI; HETEROLOGOUS EXPRESSION; METABOLIC ENGINEERING; MICROORGANISM METABOLIC ENGINEERING; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PUERARIA LOBATA; SACCHAROMYCES CEREVISIAE; SYNECHOCYSTIS;

ALKALOIDS; BIOLOGICAL AGENTS; BIOTECHNOLOGY; INDUSTRIAL MICROBIOLOGY; METABOLIC ENGINEERING; METABOLIC NETWORKS AND PATHWAYS; PLANTS; TERPENES;

EID: 84872172091     PISSN: 01681656     EISSN: 18734863     Source Type: Journal    
DOI: 10.1016/j.jbiotec.2012.06.001     Document Type: Article

References (132)

1. Ajikumar P.K., Xiao W.H., Tyo K.E., Wang Y., Simeon F., Leonard E., Mucha O., Phon T.H., Pfeifer B., Stephanopoulos G. Isoprenoid pathway optimization for Taxol precursor overproduction in Escherichia coli. Science 2010, 330:70-74.
2. Alam P., Abdin M.Z. Over-expression of HMG-CoA reductase and amorpha-4,11-diene synthase genes in Artemisia annua L. and its influence on artemisinin content. Plant Cell Reports 2011, 30:1919-1928.
3. Alper H., Fischer C., Nevoigt E., Stephanopoulos G. Tuning genetic control through promoter engineering. Proceedings of the National Academy of Sciences of the United States of America 2005, 102:12678-12683.
4. Alper H., Stephanopoulos G. Uncovering the gene knockout landscape for improved lycopene production in E. coli. Applied Microbiology and Biotechnology 2008, 78:801-810.
5. Austin M.B., Bowman M.E., Ferrer J.L., Schroder J., Noel J.P. An aldol switch discovered in stilbene synthases mediates cyclization specificity of type III polyketide synthases. Chemistry and Biology 2004, 11:1179-1194.
6. Becker J., Wittmann C. Bio-based production of chemicals materials and fuels - Corynebacterium glutamicum as versatile cell factory. Current Opinion in Biotechnology 2011, 23:1-10.
7. Becker J.V., Armstrong G.O., van der Merwe M.J., Lambrechts M.G., Vivier M.A., Pretorius I.S. Metabolic engineering of Saccharomyces cerevisiae for the synthesis of the wine-related antioxidant resveratrol. FEMS Yeast Research 2003, 4:79-85.
8. Beekwilder J., Wolswinkel R., Jonker H., Hall R., de Vos C.H., Bovy A. Production of resveratrol in recombinant microorganisms. Applied and Environment Microbiology 2006, 72:5670-5672.
9. Bhuvaneswari V., Nagini S. Lycopene: a review of its potential as an anticancer agent. Current Medicinal Chemistry - Anti-Cancer Agents 2005, 5:627-635.
10. Blanusa M., Schenk A., Sadeghi H., Marienhagen J., Schwaneberg U. Phosphorothioate-based ligase-independent gene cloning (PLICing): an enzyme-free and sequence-independent cloning method. Analytical Biochemistry 2010, 406:141-146.
11. Boghigian B.A., Salas D., Ajikumar P.K., Stephanopoulos G., Pfeifer B.A. Analysis of heterologous taxadiene production in K- and B-derived Escherichia coli. Applied Microbiology and Biotechnology 2012, 93:1651-1661.
12. Bohlmann J., Keeling C.I. Terpenoid biomaterials. Plant Journal 2008, 54:656-669.
13. Chang M.C., Eachus R.A., Trieu W., Ro D.K., Keasling J.D. Engineering Escherichia coli for production of functionalized terpenoids using plant P450s. Nature Chemical Biology 2007, 3:274-277.
14. Chemler J.A., Fowler Z.L., McHugh K.P., Koffas M.A. Improving NADPH availability for natural product biosynthesis in Escherichia coli by metabolic engineering. Metabolic Engineering 2010, 12:96-104.
15. Chemler J.A., Koffas M.A. Metabolic engineering for plant natural product biosynthesis in microbes. Current Opinion in Biotechnology 2008, 19:597-605.
16. Choi H.S., Lee S.Y., Kim T.Y., Woo H.M. In silico identification of gene amplification targets for improvement of lycopene production. Applied and Environment Microbiology 2010, 76:3097-3105.
17. Clere N., Faure S., Martinez M.C., Andriantsitohaina R. Anticancer properties of flavonoids: roles in various stages of carcinogenesis. Cardiovascular & Hematological Agents in Medicinal Chemistry 2011, 9:62-77.
18. Covello P.S. Making artemisinin. Phytochemistry 2008, 69:2881-2885.
19. Croteau R., Ketchum R.E., Long R.M., Kaspera R., Wildung M.R. Taxol biosynthesis and molecular genetics. Phytochemistry Reviews 2006, 5:75-97.
20. Das A., Yoon S.H., Lee S.H., Kim J.Y., Oh D.K., Kim S.W. An update on microbial carotenoid production: application of recent metabolic engineering tools. Applied Microbiology and Biotechnology 2007, 77:505-512.
21. Davin L.B., Lewis N.G. Dirigent phenoxy radical coupling: advances and challenges. Current Opinion in Biotechnology 2005, 16:398-406.
22. Diaz E., Ferrandez A., Prieto M.A., Garcia J.L. Biodegradation of aromatic compounds by Escherichia coli. Microbiology and Molecular Biology Reviews 2001, 65:523-569.
23. Dietrich J.A., Yoshikuni Y., Fisher K.J., Woolard F.X., Ockey D., McPhee D.J., Renninger N.S., Chang M.C.Y., Baker D., Keasling J.D. A novel semi-biosynthetic route for artemisinin production using engineered substrate-promiscuous P450(BM3). ACS Chemical Biology 2009, 4:261-267.
24. Du J., Shao Z., Zhao H. Engineering microbial factories for synthesis of value-added products. Journal of Industrial Microbiology and Biotechnology 2011, 38:873-890.
25. Ducat D.C., Way J.C., Silver P.A. Engineering cyanobacteria to generate high-value products. Trends in Biotechnology 2011, 29:95-103.
26. Duvick J., Fu A., Muppirala U., Sabharwal M., Wilkerson M.D., Lawrence C.J., Lushbough C., Brendel V. PlantGDB: a resource for comparative plant genomics. Nucleic Acids Research 2008, 36:D959-D965.
27. Engels B., Dahm P., Jennewein S. Metabolic engineering of taxadiene biosynthesis in yeast as a first step towards Taxol (Paclitaxel) production. Metabolic Engineering 2008, 10:201-206.
28. Fowler Z.L., Gikandi W.W., Koffas M.A. Increased malonyl coenzyme A biosynthesis by tuning the Escherichia coli metabolic network and its application to flavanone production. Applied and Environment Microbiology 2009, 75:5831-5839.
29. Gao X., Wang P., Tang Y. Engineered polyketide biosynthesis and biocatalysis in Escherichia coli. Applied Microbiology and Biotechnology 2010, 88:1233-1242.
30. Gresele P., Cerletti C., Guglielmini G., Pignatelli P., de Gaetano G., Violi F. Effects of resveratrol and other wine polyphenols on vascular function: an update. The Journal of Nutritional Biochemistry 2011, 22:201-211.
31. Guo W., Kong E., Meydani M. Dietary polyphenols, inflammation, and cancer. Nutrition and Cancer 2009, 61:807-810.
32. Hawkins K.M., Smolke C.D. Production of benzylisoquinoline alkaloids in Saccharomyces cerevisiae. Nature Chemical Biology 2008, 4:564-573.
33. Hemmati S., von Heimendahl C.B.I., Klaes M., Alfermann A.W., Schmidt T.J., Fuss E. Pinoresinol-Lariciresinol reductases with opposite enantiospecificity determine the enantiomeric composition of lignans in the different organs of Linum usitatissimum L. Planta Medica 2010, 76:928-934.
34. Horinouchi S. Combinatorial biosynthesis of non-bacterial and unnatural flavonoids stilbenoids and curcuminoids by microorganisms. Journal of Antibiotics 2008, 61:709-728.
35. Horinouchi S. Combinatorial biosynthesis of plant medicinal polyketides by microorganisms. Current Opinion in Chemical Biology 2009, 13:197-204.
36. Hunter W.N. The non-mevalonate pathway of isoprenoid precursor biosynthesis. Journal of Biological Chemistry 2007, 282:21573-21577.
37. Ionkova I. Anticancer lignans - from discovery to biotechnology. Mini Reviews in Medicinal Chemistry 2011, 11:843-856.
38. Jennewein S., Long R.M., Williams R.M., Croteau R. Cytochrome p450 taxadiene 5-alpha-hydroxylase, a mechanistically unusual monooxygenase catalyzing the first oxygenation step of taxol biosynthesis. Chemistry and Biology 2004, 11:379-387.
39. Jin Y.S., Stephanopoulos G. Multi-dimensional gene target search for improving lycopene biosynthesis in Escherichia coli. Metabolic Engineering 2007, 9:337-347.
40. Julsing M.K., Koulman A., Woerdenbag H.J., Quax W.J., Kayser O. Combinatorial biosynthesis of medicinal plant secondary metabolites. Biomolecular Engineering 2006, 23:265-279.
41. Kaspera R., Croteau R. Cytochrome P450 oxygenases of Taxol biosynthesis. Phytochemistry Reviews 2006, 5:433-444.
42. Keasling J. From yeast to alkaloids. Nature Chemical Biology 2008, 4:524-525.
43. Kelkel M., Schumacher M., Dicato M., Diederich M. Antioxidant and anti-proliferative properties of lycopene. Free Radical Research 2011, 45:925-940.
44. Kim M.K., Jeon J.H., Fujita M., Davin L.B., Lewis N.G. The western red cedar (Thuja plicata) 8-8' DIRIGENT family displays diverse expression patterns and conserved monolignol coupling specificity. Plant Molecular Biology 2002, 49:199-214.
45. Kingston D.G. Recent advances in the chemistry of taxol. Journal of Natural Products 2000, 63:726-734.
46. Kiselev K.V. Perspectives for production and application of resveratrol. Applied Microbiology and Biotechnology 2011, 90:417-425.
47. Klein-Marcuschamer D., Ajikumar P.K., Stephanopoulos G. Engineering microbial cell factories for biosynthesis of isoprenoid molecules: beyond lycopene. Trends in Biotechnology 2007, 25:417-424.
48. Knutson M.D., Leeuwenburgh C. Resveratrol and novel potent activators of SIRT1: effects on aging and age-related diseases. Nutrition Reviews 2008, 66:591-596.
49. Koehn F.E., Carter G.T. The evolving role of natural products in drug discovery. Nature Reviews Drug Discovery 2005, 4:206-220.
50. Kolewe M.E., Gaurav V., Roberts S.C. Pharmaceutically active natural product synthesis and supply via plant cell culture technology. Molecular Pharmacology 2008, 5:243-256.
51. Korkina L., Kostyuk V., De Luca C., Pastore S. Plant phenylpropanoids as emerging anti-inflammatory agents. Mini Reviews in Medicinal Chemistry 2011, 11:823-835.
52. Krubasik P., Kobayashi M., Sandmann G. Expression and functional analysis of a gene cluster involved in the synthesis of decaprenoxanthin reveals the mechanisms for C50 carotenoid formation. European Journal of Biochemistry 2001, 268:3702-3708.
53. Kuzuyama T., Seto H. Diversity of the biosynthesis of the isoprene units. Natural Products Reports 2003, 20:171-183.
54. Lartigue C., Vashee S., Algire M.A., Chuang R.Y., Benders G.A., Ma L., Noskov V.N., Denisova E.A., Gibson D.G., Assad-Garcia N., Alperovich N., Thomas D.W., Merryman C., Hutchison C.A., Smith H.O., Venter J.C., Glass J.I. Creating bacterial strains from genomes that have been cloned and engineered in yeast. Science 2009, 325:1693-1696.
55. Lee E.K., Jin Y.W., Park J.H., Yoo Y.M., Hong S.M., Amir R., Yan Z., Kwon E., Elfick A., Tomlinson S., Halbritter F., Waibel T., Yun B.W., Loake G.J. Cultured cambial meristematic cells as a source of plant natural products. Nature Biotechnology 2010, 28:1213-1217.
56. Lenihan J.R., Tsuruta H., Diola D., Renninger N.S., Regentin R. Developing an industrial artemisinic acid fermentation process to support the cost-effective production of antimalarial artemisinin-based combination therapies. Biotechnology Progress 2008, 24:1026-1032.
57. Leonard E., Lim K.H., Saw P.N., Koffas M.A. Engineering central metabolic pathways for high-level flavonoid production in Escherichia coli. Applied and Environment Microbiology 2007, 73:3877-3886.
58. Leonard E., Runguphan W., O'Connor S., Prather K.J. Opportunities in metabolic engineering to facilitate scalable alkaloid production. Nature Chemical Biology 2009, 5:292-300.
59. Levesque F., Seeberger P.H. Continuous-flow synthesis of the anti-malaria drug Artemisinin. Angewandte Chemie (International ed. in English) 2012, 51:1706-1709.
60. Li J.W., Vederas J.C. Drug discovery and natural products: end of an era or an endless frontier?. Science 2009, 325:161-165.
61. Licciardi P.V., Underwood J.R. Plant-derived medicines: a novel class of immunological adjuvants. International Immunopharmacology 2011, 11:390-398.
62. Lim C.G., Fowler Z.L., Hueller T., Schaffer S., Koffas M.A. High-yield resveratrol production in engineered Escherichia coli. Applied and Environment Microbiology 2011, 77:3451-3460.
63. Lindahl A.L., Olsson M.E., Mercke P., Tollbom O., Schelin J., Brodelius M., Brodelius P.E. Production of the artemisinin precursor amorpha-4,11-diene by engineered Saccharomyces cerevisiae. Biotechnology Letters 2006, 28:571-580.
64. Lindberg P., Park S., Melis A. Engineering a platform for photosynthetic isoprene production in cyanobacteria, using Synechocystis as the model organism. Metabolic Engineering 2010, 12:70-79.
65. Lv M., Xu H. Recent advances in semisynthesis, biosynthesis, biological activities, mode of action, and structure-activity relationship of podophyllotoxins: an update (2008-2010). Mini Reviews in Medicinal Chemistry 2011, 11:901-909.
66. Malla S., Koffas M.A., Kazlauskas R.J., Kim B.G. Production of 7-O-Methyl Aromadendrin, a medicinally valuable flavonoid, in Escherichia coli. Applied and Environment Microbiology 2012, 78:684-694.
67. Martin V.J., Pitera D.J., Withers S.T., Newman J.D., Keasling J.D. Engineering a mevalonate pathway in Escherichia coli for production of terpenoids. Nature Biotechnology 2003, 21:796-802.
68. Meyer V., Wu B., Ram A.F.J. Aspergillus as a multi-purpose cell factory: current status and perspectives. Biotechnology Letters 2011, 33:469-476.
69. Minami H., Kim J.S., Ikezawa N., Takemura T., Katayama T., Kumagai H., Sato F. Microbial production of plant benzylisoquinoline alkaloids. Proceedings of the National Academy of Sciences of the United States of America 2008, 105:7393-7398.
70. Minto R.E., Blacklock B.J. Biosynthesis and function of polyacetylenes and allied natural products. Progress in Lipid Research 2008, 47:233-306.
71. Mishra B.B., Tiwari V.K. Natural products: an evolving role in future drug discovery. European Journal of Medical Chemistry 2011, 46:4769-4807.
72. Miyahisa I., Kaneko M., Funa N., Kawasaki H., Kojima H., Ohnishi Y., Horinouchi S. Efficient production of (2S)-flavanones by Escherichia coli containing an artificial biosynthetic gene cluster. Applied Microbiology and Biotechnology 2005, 68:498-504.
73. Moldrup M.E., Geu-Flores F., Olsen C.E., Halkier B.A. Modulation of sulfur metabolism enables efficient glucosinolate engineering. BMC Biotechnology 2011, 11:12.
74. Nakagawa A., Minami H., Kim J.S., Koyanagi T., Katayama T., Sato F., Kumagai H. A bacterial platform for fermentative production of plant alkaloids. Nature Communications 2011, 2:326.
75. Nakagawa A., Minami H., Kim J.S., Koyanagi T., Katayama T., Sato F., Kumagai H. Bench-top fermentative production of plant benzylisoquinoline alkaloids using a bacterial platform. Bioengineered Bugs 2012, 3:49-53.
76. Namitha K.K., Negi P.S. Chemistry and biotechnology of carotenoids. Critical Reviews in Food Science and Nutrition 2010, 50:728-760.
77. Netzer R., Stafsnes M.H., Andreassen T., Goksoyr A., Bruheim P., Brautaset T. Biosynthetic pathway for gamma-cyclic sarcinaxanthin in Micrococcus luteus: heterologous expression and evidence for diverse and multiple catalytic functions of C(50) carotenoid cyclases. Journal of Bacteriology 2010, 192:5688-5699.
78. Neutelings G. Lignin variability in plant cell walls: contribution of new models. Plant Science 2011, 181:379-386.
79. Nevoigt E., Kohnke J., Fischer C.R., Alper H., Stahl U., Stephanopoulos G. Engineering of promoter replacement cassettes for fine-tuning of gene expression in Saccharomyces cerevisiae. Applied and Environment Microbiology 2006, 72:5266-5273.
80. Newhouse T., Baran P.S., Hoffmann R.W. The economies of synthesis. Chemical Society Reviews 2009, 38:3010-3021.
81. Newman D.J. Natural products as leads to potential drugs: an old process or the new hope for drug discovery. Journal of Medicinal Chemistry 2008, 51:2589-2599.
82. Newman D.J., Cragg G.M. Natural products as sources of new drugs over the last 25 years. Journal of Natural Products 2007, 70:461-477.
83. Niraula N.P., Kim S.H., Sohng J.K., Kim E.S. Biotechnological doxorubicin production: pathway and regulation engineering of strains for enhanced production. Applied Microbiology and Biotechnology 2010, 87:1187-1194.
84. Osbourn A.E., Lanzotti V. Plant-Derived Natural Products - Synthesis, Function, and Application 2009, Springer, Heidelberg, London, New York. first ed.
85. Peralta-Yahya P.P., Ouellet M., Chan R., Mukhopadhyay A., Keasling J.D., Lee T.S. Identification and microbial production of a terpene-based advanced biofuel. Nature Communications 2011, 2:483.
86. Pfleger B.F., Pitera D.J., Smolke C.D., Keasling J.D. Combinatorial engineering of intergenic regions in operons tunes expression of multiple genes. Nature Biotechnology 2006, 24:1027-1032.
87. Phillips M.A., Leon P., Boronat A., Rodriguez-Concepcion M. The plastidial MEP pathway: unified nomenclature and resources. Trends in Plant Science 2008, 13:619-623.
88. Pickel B., Constantin M.A., Pfannstiel J., Conrad J., Beifuss U., Schaller A. An enantiocomplementary dirigent protein for the enantioselective laccase-catalyzed oxidative coupling of phenols. Angewandte Chemie (International ed. in English) 2010, 49:202-204.
89. Pickens L.B., Tang Y., Chooi Y.H. Metabolic engineering for the production of natural products. Annual Review of Chemical and Biomolecular Engineering 2011, 2:211-236.
90. Pitera D.J., Paddon C.J., Newman J.D., Keasling J.D. Balancing a heterologous mevalonate pathway for improved isoprenoid production in Escherichia coli. Metabolic Engineering 2007, 9:193-207.
91. Pollier J., Moses T., Goossens A. Combinatorial biosynthesis in plants: a (p)review on its potential and future exploitation. Natural Products Reports 2011, 28:1897-1916.
92. Posfai G., Plunkett G., Feher T., Frisch D., Keil G.M., Umenhoffer K., Kolisnychenko V., Stahl B., Sharma S.S., de Arruda M., Burland V., Harcum S.W., Blattner F.R. Emergent properties of reduced-genome Escherichia coli. Science 2006, 312:1044-1046.
93. Qi W.W., Vannelli T., Breinig S., Ben-Bassat A., Gatenby A.A., Haynie S.L., Sariaslani F.S. Functional expression of prokaryotic and eukaryotic genes in Escherichia coli for conversion of glucose to p-hydroxystyrene. Metabolic Engineering 2007, 9:268-276.
94. Ro D.K., Douglas C.J. Reconstitution of the entry point of plant phenylpropanoid metabolism in yeast (Saccharomyces cerevisiae): implications for control of metabolic flux into the phenylpropanoid pathway. Journal of Biological Chemistry 2004, 279:2600-2607.
95. Ro D.K., Ouellet M., Paradise E.M., Burd H., Eng D., Paddon C.J., Newman J.D., Keasling J.D. Induction of multiple pleiotropic drug resistance genes in yeast engineered to produce an increased level of anti-malarial drug precursor, artemisinic acid. BMC Biotechnology 2008, 8:83.
96. Ro D.K., Paradise E.M., Ouellet M., Fisher K.J., Newman K.L., Ndungu J.M., Ho K.A., Eachus R.A., Ham T.S., Kirby J., Chang M.C., Withers S.T., Shiba Y., Sarpong R., Keasling J.D. Production of the antimalarial drug precursor artemisinic acid in engineered yeast. Nature 2006, 440:940-943.
97. Roberts S.C. Production and engineering of terpenoids in plant cell culture. Nature Chemical Biology 2007, 3:387-395.
98. Rohmer M., Knani M., Simonin P., Sutter B., Sahm H. Isoprenoid biosynthesis in bacteria: a novel pathway for the early steps leading to isopentenyl diphosphate. Biochemical Journal 1993, 295:517-524.
99. Rude M.A., Schirmer A. New microbial fuels: a biotech perspective. Current Opinion in Microbiology 2009, 12:274-281.
100. Salis H.M., Mirsky E.A., Voigt C.A. Automated design of synthetic ribosome binding sites to control protein expression. Nature Biotechnology 2009, 27:946-950.
101. Santos C.N., Koffas M., Stephanopoulos G. Optimization of a heterologous pathway for the production of flavonoids from glucose. Metabolic Engineering 2011, 13:392-400.
102. Schewe H., Holtmann D., Schrader J. P450(BM-3)-catalyzed whole-cell biotransformation of alpha-pinene with recombinant Escherichia coli in an aqueous-organic two-phase system. Applied Microbiology and Biotechnology 2009, 83:849-857.
103. Schmidt I., Schewe H., Gassel S., Jin C., Buckingham J., Humbelin M., Sandmann G., Schrader J. Biotechnological production of astaxanthin with Phaffia rhodozyma/Xanthophyllomyces dendrorhous. Applied Microbiology and Biotechnology 2011, 89:555-571.
104. Schwab W. Metabolome diversity: too few genes, too many metabolites?. Phytochemistry 2003, 62:837-849.
105. Shao Z., Zhao H. DNA assembler, an in vivo genetic method for rapid construction of biochemical pathways. Nucleic Acids Research 2009, 37:e16.
106. Shivange A.V., Marienhagen J., Mundhada H., Schenk A., Schwaneberg U. Advances in generating functional diversity for directed protein evolution. Current Opinion in Chemical Biology 2009, 13:19-25.
107. Singh R. Facts, growth, and opportunities in industrial biotechnology. Organic Process Research and Development 2011, 15:175-179.
108. Sonderby I.E., Geu-Flores F., Halkier B.A. Biosynthesis of glucosinolates - gene discovery and beyond. Trends in Plant Science 2010, 15:283-290.
109. Sowbhagya H.B., Chitra V.N. Enzyme-assisted extraction of flavorings and colorants from plant materials. Critical Reviews in Food Science and Nutrition 2010, 50:146-161.
110. Tan A.C., Konczak I., Sze D.M., Ramzan I. Molecular pathways for cancer chemoprevention by dietary phytochemicals. Nutrition and Cancer 2011, 63:495-505.
111. Tsuruta H., Paddon C.J., Eng D., Lenihan J.R., Horning T., Anthony L.C., Regentin R., Keasling J.D., Renninger N.S., Newman J.D. High-level production of amorpha-4,11-diene, a precursor of the antimalarial agent artemisinin, in Escherichia coli. PLoS ONE 2009, 4:e4489.
112. Tyo K.E., Ajikumar P.K., Stephanopoulos G. Stabilized gene duplication enables long-term selection-free heterologous pathway expression. Nature Biotechnology 2009, 27:760-765.
113. Tyo K.E., Alper H.S., Stephanopoulos G.N. Expanding the metabolic engineering toolbox: more options to engineer cells. Trends in Biotechnology 2007, 25:132-137.
114. Vannelli T., Wei Qi W., Sweigard J., Gatenby A.A., Sariaslani F.S. Production of p-hydroxycinnamic acid from glucose in Saccharomyces cerevisiae and Escherichia coli by expression of heterologous genes from plants and fungi. Metabolic Engineering 2007, 9:142-151.
115. Verhoef S., Wierckx N., Westerhof R.G., de Winde J.H., Ruijssenaars H.J. Bioproduction of p-hydroxystyrene from glucose by the solvent-tolerant bacterium Pseudomonas putida S12 in a two-phase water-decanol fermentation. Applied and Environment Microbiology 2009, 75:931-936.
116. Vickers C.E., Possell M., Laothawornkitkul J., Ryan A.C., Hewitt C.N., Mullineaux P.M. Isoprene synthesis in plants: lessons from a transgenic tobacco model. Plant, Cell & Environment 2011, 34:1043-1053.
117. Vogt T. Phenylpropanoid biosynthesis. Molecular Plant 2010, 3:2-20.
118. Wang H.H., Isaacs F.J., Carr P.A., Sun Z.Z., Xu G., Forest C.R., Church G.M. Programming cells by multiplex genome engineering and accelerated evolution. Nature 2009, 460:894-898.
119. Wang Y., Chen S., Yu O. Metabolic engineering of flavonoids in plants and microorganisms. Applied Microbiology and Biotechnology 2011, 91:949-956.
120. Wang Y., Halls C., Zhang J., Matsuno M., Zhang Y., Yu O. Stepwise increase of resveratrol biosynthesis in yeast Saccharomyces cerevisiae by metabolic engineering. Metabolic Engineering 2011, 13:455-463.
121. Watts K.T., Lee P.C., Schmidt-Dannert C. Biosynthesis of plant-specific stilbene polyketides in metabolically engineered Escherichia coli. BMC Biotechnology 2006, 6:22.
122. Wendisch V.F., Bott M., Eikmanns B.J. Metabolic engineering of Escherichia coli and Corynebacterium glutamicum for biotechnological production of organic acids and amino acids. Current Opinion in Microbiology 2006, 9:268-274.
123. Wiechert W., Noack S. Mechanistic pathway modeling for industrial biotechnology: challenging but worthwhile. Current Opinion in Biotechnology 2011, 22:604-610.
124. Wu L., Wang X., Xu W., Farzaneh F., Xu R. The structure and pharmacological functions of coumarins and their derivatives. Current Medicinal Chemistry 2009, 16:4236-4260.
125. Wu S., Chappell J. Metabolic engineering of natural products in plants; tools of the trade and challenges for the future. Current Opinion in Biotechnology 2008, 19:145-152.
126. Xu P., Ranganathan S., Fowler Z.L., Maranas C.D., Koffas M.A. Genome-scale metabolic network modeling results in minimal interventions that cooperatively force carbon flux towards malonyl-CoA. Metabolic Engineering 2011, 13:578-587.
127. Yang G., Withers S.G. Ultrahigh-throughput FACS-based screening for directed enzyme evolution. Chembiochem 2009, 10:2704-2715.
128. Yang J., Zhao G., Sun Y., Zheng Y., Jiang X., Liu W., Xian M. Bio-isoprene production using exogenous MVA pathway and isoprene synthase in Escherichia coli. Bioresource Technology 2012, 104:642-647.
129. Zha W., Rubin-Pitel S.B., Shao Z., Zhao H. Improving cellular malonyl-CoA level in Escherichia coli via metabolic engineering. Metabolic Engineering 2009, 11:192-198.
130. Zhang W.Y., Lee J.J., Kim I.S., Kim Y., Park J.S., Myung C.S. 7-O-methylaromadendrin stimulates glucose uptake and improves insulin resistance in vitro. Biological and Pharmaceutical Bulletin 2010, 33:1494-1499.
131. Zhang Y.S., Li S.Z., Li J., Pan X.Q., Cahoon R.E., Jaworski J.G., Wang X.M., Jez J.M., Chen F., Yu O. Using unnatural protein fusions to engineer resveratrol biosynthesis in yeast and mammalian cells. Journal of the American Chemical Society 2006, 128:13030-13031.
132. Zhao Y., Yang J., Qin B., Li Y., Sun Y., Su S., Xian M. Biosynthesis of isoprene in Escherichia coli via methylerythritol phosphate (MEP) pathway. Applied Microbiology and Biotechnology 2011, 90:1915-1922.